Medical Health Cluster

Vacunas

Mayor riesgo de herpes zoster en adultos 50 años diagnosticados de COVID-19 en los Estados Unidos

Estudio retrospectivo de cohortes realizado en los Estados Unidos para evaluar el riesgo de desarrollar un cuadro de herpes zóster tras un diagnóstico de COVID-19. Para ello comparan la incidencia de zóster en los adultos mayores de cincuenta o más años que padecieron COVID-19 con los que nunca tuvieron ese […]

Read More

As Unexplained Hepatitis Spreads, WHO Urges Action

Despite recent progress, more than 350 million people globally live with viral hepatitis and more than 1 million die annually—a greater toll than from HIV and malaria combined. Amid unexplained increases in childhood hepatitis cases in 34 countries, the World Hepatitis Alliance and World Health Organization (WHO) urged renewed efforts to eliminate […]

Read More

Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association

Evaluation of COVID-19 vaccine booster effectiveness is essential as new variants of SARS-CoV-2 emerge. Data support the effectiveness of booster doses in preventing severe disease and hospitalization; however, the association with reducing incident SARS-CoV-2 infections is not clear.1-3 We compared the incidence of SARS-CoV-2 infection in players and staff of the […]

Read More

What to Know About the Newest, Most Contagious Omicron Subvariants

It only took about a month for BA.2.12.1, an Omicron subvariant, to cause most of the new COVID-19 cases in the U.S. since scientists first spotted it in the country. But even newer iterations of the Omicron variant are spreading rapidly through the U.S. and are poised to outcompete past versions […]

Read More

Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis

Abstract BACKGROUND Sabizabulin is an oral, novel microtubule disruptor that has dual antiviral and anti-inflammatory activities in preclinical models. METHODS A randomized, multicenter placebo-controlled phase 3 clinical trial was conducted with hospitalized patients with moderate to severe Covid-19 who were at high risk for acute respiratory distress syndrome (ARDS) and […]

Read More

Quinta ola de COVID-19: Estos son los posibles escenarios de su avance, según la UNAM

México atraviesa su quinta ola de COVID-19, esto luego de más de un mes con aumentos de casos diarios, que comenzaron con cifras de 6 mil nuevos contagios y que actualmente se han superado los 31 mil en 24 horas, teniendo cifras similares a las de enero y febrero de este […]

Read More